OpenAlex
PricingAboutJobs
Log inGet started
Work

Dopamine Receptor Signaling and Current and Future Antipsychotic Drugs

HTML

Year: 2012
Type: book-chapter
Source: Handbook of experimental pharmacology
Parent work: Current Antipsychotics
DOI: 10.1007/978-3-642-25761-2_3
Authors: Kevin N. Boyd, Richard B. Mailman
Institutions: Pennsylvania State University, Penn State Milton S. Hershey Medical Center
Language: English

Topic: Schizophrenia research and treatment
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: dopamine D2 receptor, dopamine D1 receptor, antipsychotic drugs, aripiprazole, functional selectivity, dopamine signaling, cAMP signaling, negative symptoms of schizophrenia, cognitive symptoms, partial agonists, drug discovery
SDG: Good health and well-being

Open Access status: green

Funders: National Institute of Mental Health, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, National Institute of Environmental Health Sciences
Awards: Functional Selectivity: A Novel Approach for CNS Drug Discovery, MOLECULAR REGULATION OF D1 DOPAMINE RECEPTOR FUNCTION, NOVEL MOLECULAR SITE FOR ANTIDOPAMINERGIC ACTION, Predoctoral Training in Pharmacological Sciences, Pre- and Postdoctoral Training in Toxicology
OpenAlex ID: W1830139488
FWCI: 21.47
Cites: 229
Cited by: 115
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security